These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2844199)

  • 41. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.
    Tas F; Aydiner A; Topuz E; Yasasever V; Karadeniz A; Saip P
    J Exp Clin Cancer Res; 2000 Dec; 19(4):477-81. PubMed ID: 11277326
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical evaluation of five tumor marker assay in patients with lung cancer.
    Mizushima Y; Tsuji H; Izumi S; Hirata H; Kin Y; Kawasaki A; Matsui S; Yano S
    Anticancer Res; 1991; 11(1):91-5. PubMed ID: 2018388
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Four-color multiparameter DNA flow cytometric method to study phenotypic intratumor heterogeneity in cervical cancer.
    Corver WE; Koopman LA; van der Aa J; Regensburg M; Fleuren GJ; Cornelisse CJ
    Cytometry; 2000 Feb; 39(2):96-107. PubMed ID: 10679727
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer.
    Foa P; Fornier M; Miceli R; Seregni E; Santambrogio L; Nosotti M; Cataldo I; Sala M; Caldiera S; Bombardieri E
    Anticancer Res; 1999; 19(4C):3613-8. PubMed ID: 10629660
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neural markers in carcinoma of the lung.
    Dhillon AP; Rode J; Dhillon DP; Moss E; Thompson RJ; Spiro SG; Corrin B
    Br J Cancer; 1985 May; 51(5):645-52. PubMed ID: 2986665
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of epithelial- and neural type of intermediate filament proteins in human lung tumors.
    Ramaekers F; Broers J; Rot MK; Oostendorp T; Wagenaar S; Vooijs P
    Acta Histochem Suppl; 1987; 34():45-56. PubMed ID: 3033739
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The prognostic value of both neuron-specific enolase (NSE) and Cyfra21-1 in small cell lung cancer.
    Ando S; Suzuki M; Yamamoto N; Iida T; Kimura H
    Anticancer Res; 2004; 24(3b):1941-6. PubMed ID: 15274381
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Carcinoembryonic antigen, neuron-specific enolase and creatine kinase-BB as tumor markers for carcinoma of the lung.
    Nikliński J; Furman M; Palynyczko Z; Laudański J; Bułatowicz J
    Neoplasma; 1991; 38(6):645-51. PubMed ID: 1766488
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of the prognostic significance of cytosolic determination of CA 125 tumor-associated antigen, carcinoembryonic antigen and squamous cell carcinoma antigen in patients with nonsmall cell lung carcinoma.
    Picardo AL; Diez M; Torres A; Maestro M; Ortega D; Hernando F; Gómez A; Garcia-Asenjo J; Balibrea JL
    Cancer; 1996 Mar; 77(6):1066-72. PubMed ID: 8635125
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Simultaneous measurement of two cellular antigens and DNA using fluorescein-isothiocyanate, R-phycoerythrin, and propidium iodide on a standard FACScan.
    Corver WE; Cornelisse CJ; Fleuren GJ
    Cytometry; 1994 Feb; 15(2):117-28. PubMed ID: 8168399
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of electron microscopy and immunohistochemistry in the diagnosis and understanding of lung neoplasms.
    Hammar S
    Clin Lab Med; 1987 Mar; 7(1):1-30. PubMed ID: 3030610
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Tumor markers for lung neoplasm].
    Sekido Y
    Nihon Rinsho; 2002 May; 60 Suppl 5():229-32. PubMed ID: 12101663
    [No Abstract]   [Full Text] [Related]  

  • 53. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases.
    Schneider J; Philipp M; Velcovsky HG; Morr H; Katz N
    Anticancer Res; 2003; 23(2A):885-93. PubMed ID: 12820318
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intracellular pH, esterase activity, and DNA measurements of human lung carcinomas by flow cytometry.
    Liewald F; Demmel N; Wirsching R; Kahle H; Valet G
    Cytometry; 1990; 11(3):341-8. PubMed ID: 2340771
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Flow cytometric analysis of tumor antigen TA-4 in cervical squamous cells.
    Sasaki K; Nagai M; Kato H; Torigoe T; Nagamine Y; Takahashi M
    Gan; 1984 Aug; 75(8):703-6. PubMed ID: 6386588
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer].
    Pan QR; Zhang X; Xu ZF; Zheng S
    Ai Zheng; 2002 Feb; 21(2):196-9. PubMed ID: 12479076
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiple sequential biomarkers in monitoring patients with carcinoma of the lung.
    Aroney RS; Dermody WC; Aldenderfer P; Parsons P; McNitt K; Marangos PJ; Whitacre MY; Ruddon RW; Wiernik PH; Aisner J
    Cancer Treat Rep; 1984 Jun; 68(6):859-66. PubMed ID: 6329508
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical significance of serum SCC Ag in patients with squamous cell carcinoma of the lung].
    Zeng L
    Zhonghua Wai Ke Za Zhi; 1993 Mar; 31(3):143-5. PubMed ID: 8223022
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antigenic heterogeneity of human lung cancers.
    Harłozińska A; Richter R; Albert Z; Zawadzka H
    J Natl Cancer Inst; 1983 Mar; 70(3):427-33. PubMed ID: 6300497
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cell kinetic analysis of mixed populations using three-color fluorescence flow cytometry.
    Begg AC; Hofland I
    Cytometry; 1991; 12(5):445-54. PubMed ID: 1718673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.